Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain.
Identifieur interne : 000255 ( Main/Exploration ); précédent : 000254; suivant : 000256Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain.
Auteurs : Isabel Jimenez-Trujillo [Espagne] ; Ana L Pez-De Andrés ; Valentín Hernández-Barrera ; Pilar Carrasco-Garrido ; Juana María Santos-Sancho ; Rodrigo Jiménez-GarcíaSource :
- Human vaccines & immunotherapeutics [ 2164-554X ] ; 2013.
Descripteurs français
- KwdFr :
- Adhésion au traitement médicamenteux (MeSH), Adulte d'âge moyen (MeSH), Complications du diabète (prévention et contrôle), Enquêtes et questionnaires (MeSH), Espagne (MeSH), Facteurs temps (MeSH), Femelle (MeSH), Grippe humaine (prévention et contrôle), Humains (MeSH), Mâle (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Vaccination (statistiques et données numériques), Vaccins antigrippaux (administration et posologie), Études transversales (MeSH).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- prévention et contrôle : Complications du diabète, Grippe humaine.
- statistiques et données numériques : Vaccination.
- Adhésion au traitement médicamenteux, Adulte d'âge moyen, Enquêtes et questionnaires, Espagne, Facteurs temps, Femelle, Humains, Mâle, Sujet âgé, Sujet âgé de 80 ans ou plus, Études transversales.
English descriptors
- KwdEn :
- Aged (MeSH), Aged, 80 and over (MeSH), Cross-Sectional Studies (MeSH), Diabetes Complications (prevention & control), Female (MeSH), Humans (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (prevention & control), Male (MeSH), Medication Adherence (MeSH), Middle Aged (MeSH), Spain (MeSH), Surveys and Questionnaires (MeSH), Time Factors (MeSH), Vaccination (statistics & numerical data).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- prevention & control : Diabetes Complications, Influenza, Human.
- statistics & numerical data : Vaccination.
- Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Humans, Male, Medication Adherence, Middle Aged, Spain, Surveys and Questionnaires, Time Factors.
Abstract
A descriptive cross-sectional study was conducted for adults (aged ≥ 50 y) with diabetes. Data was obtained from the 2009 European Health Interview Survey for Spain and the 2003 and 2006 Spanish National Health Surveys. To assess influenza vaccination status, we considered the response (yes or no) to the question "Have you received the influenza vaccine in the previous season?" Both dependent and independent variables were based on the survey questionnaires. The independent variables analyzed included socio-demographic characteristics, health-related variables and use of health care services. The coverage among adults with diabetes in 2010 was 65.0% (95% CI: 62.1-67.7) compared with 41.2% (95% CI 40.0-42.4) for those without diabetes (p<0.01) adjusted OR 1.67 (95% CI: 1.40-1.99). The positive predictors of vaccine uptake among diabetic adults were: higher age, being male, the presence of associated chronic conditions and physician visits in the last 2 wk. The vaccine uptake among adults with diabetes was 61.4% (95% CI: 57.9-64.8) in 2003 and 63.8% (95% CI: 60.7-66.8) in 2006.The adjusted OR of having been vaccinated in 2010 with respect to 2003 was not significant 1.18 (95% CI: 0.97-1.44). We conclude that the levels of influenza vaccination coverage are below desirable levels among adults with diabetes. Furthermore, trend analysis in influenza vaccination coverage indicates that influenza vaccination rates in adults with diabetes have not improved in recent years. Urgent strategies for increasing vaccination coverage among diabetes sufferers are necessary especially for those aged 50-59, women, those without chronic conditions and those who are not frequent users of health care services.
DOI: 10.4161/hv.23926
PubMed: 23403458
PubMed Central: PMC3901826
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain.</title><author><name sortKey="Jimenez Trujillo, Isabel" sort="Jimenez Trujillo, Isabel" uniqKey="Jimenez Trujillo I" first="Isabel" last="Jimenez-Trujillo">Isabel Jimenez-Trujillo</name><affiliation wicri:level="1"><nlm:affiliation>Preventive Medicine Unit; Rey Juan Carlos University; Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Preventive Medicine Unit; Rey Juan Carlos University; Madrid</wicri:regionArea></affiliation></author><author><name sortKey="L Pez De Andres, Ana" sort="L Pez De Andres, Ana" uniqKey="L Pez De Andres A" first="Ana" last="L Pez-De Andrés">Ana L Pez-De Andrés</name></author><author><name sortKey="Hernandez Barrera, Valentin" sort="Hernandez Barrera, Valentin" uniqKey="Hernandez Barrera V" first="Valentín" last="Hernández-Barrera">Valentín Hernández-Barrera</name></author><author><name sortKey="Carrasco Garrido, Pilar" sort="Carrasco Garrido, Pilar" uniqKey="Carrasco Garrido P" first="Pilar" last="Carrasco-Garrido">Pilar Carrasco-Garrido</name></author><author><name sortKey="Santos Sancho, Juana Maria" sort="Santos Sancho, Juana Maria" uniqKey="Santos Sancho J" first="Juana María" last="Santos-Sancho">Juana María Santos-Sancho</name></author><author><name sortKey="Jimenez Garcia, Rodrigo" sort="Jimenez Garcia, Rodrigo" uniqKey="Jimenez Garcia R" first="Rodrigo" last="Jiménez-García">Rodrigo Jiménez-García</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23403458</idno><idno type="pmid">23403458</idno><idno type="doi">10.4161/hv.23926</idno><idno type="pmc">PMC3901826</idno><idno type="wicri:Area/Main/Corpus">00258</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00258</idno><idno type="wicri:Area/Main/Curation">000258</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000258</idno><idno type="wicri:Area/Main/Exploration">000258</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain.</title><author><name sortKey="Jimenez Trujillo, Isabel" sort="Jimenez Trujillo, Isabel" uniqKey="Jimenez Trujillo I" first="Isabel" last="Jimenez-Trujillo">Isabel Jimenez-Trujillo</name><affiliation wicri:level="1"><nlm:affiliation>Preventive Medicine Unit; Rey Juan Carlos University; Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Preventive Medicine Unit; Rey Juan Carlos University; Madrid</wicri:regionArea></affiliation></author><author><name sortKey="L Pez De Andres, Ana" sort="L Pez De Andres, Ana" uniqKey="L Pez De Andres A" first="Ana" last="L Pez-De Andrés">Ana L Pez-De Andrés</name></author><author><name sortKey="Hernandez Barrera, Valentin" sort="Hernandez Barrera, Valentin" uniqKey="Hernandez Barrera V" first="Valentín" last="Hernández-Barrera">Valentín Hernández-Barrera</name></author><author><name sortKey="Carrasco Garrido, Pilar" sort="Carrasco Garrido, Pilar" uniqKey="Carrasco Garrido P" first="Pilar" last="Carrasco-Garrido">Pilar Carrasco-Garrido</name></author><author><name sortKey="Santos Sancho, Juana Maria" sort="Santos Sancho, Juana Maria" uniqKey="Santos Sancho J" first="Juana María" last="Santos-Sancho">Juana María Santos-Sancho</name></author><author><name sortKey="Jimenez Garcia, Rodrigo" sort="Jimenez Garcia, Rodrigo" uniqKey="Jimenez Garcia R" first="Rodrigo" last="Jiménez-García">Rodrigo Jiménez-García</name></author></analytic><series><title level="j">Human vaccines & immunotherapeutics</title><idno type="eISSN">2164-554X</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Cross-Sectional Studies (MeSH)</term><term>Diabetes Complications (prevention & control)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (prevention & control)</term><term>Male (MeSH)</term><term>Medication Adherence (MeSH)</term><term>Middle Aged (MeSH)</term><term>Spain (MeSH)</term><term>Surveys and Questionnaires (MeSH)</term><term>Time Factors (MeSH)</term><term>Vaccination (statistics & numerical data)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adhésion au traitement médicamenteux (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Complications du diabète (prévention et contrôle)</term><term>Enquêtes et questionnaires (MeSH)</term><term>Espagne (MeSH)</term><term>Facteurs temps (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Humains (MeSH)</term><term>Mâle (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Vaccination (statistiques et données numériques)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Études transversales (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Diabetes Complications</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Complications du diabète</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Medication Adherence</term><term>Middle Aged</term><term>Spain</term><term>Surveys and Questionnaires</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adhésion au traitement médicamenteux</term><term>Adulte d'âge moyen</term><term>Enquêtes et questionnaires</term><term>Espagne</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A descriptive cross-sectional study was conducted for adults (aged ≥ 50 y) with diabetes. Data was obtained from the 2009 European Health Interview Survey for Spain and the 2003 and 2006 Spanish National Health Surveys. To assess influenza vaccination status, we considered the response (yes or no) to the question "Have you received the influenza vaccine in the previous season?" Both dependent and independent variables were based on the survey questionnaires. The independent variables analyzed included socio-demographic characteristics, health-related variables and use of health care services. The coverage among adults with diabetes in 2010 was 65.0% (95% CI: 62.1-67.7) compared with 41.2% (95% CI 40.0-42.4) for those without diabetes (p<0.01) adjusted OR 1.67 (95% CI: 1.40-1.99). The positive predictors of vaccine uptake among diabetic adults were: higher age, being male, the presence of associated chronic conditions and physician visits in the last 2 wk. The vaccine uptake among adults with diabetes was 61.4% (95% CI: 57.9-64.8) in 2003 and 63.8% (95% CI: 60.7-66.8) in 2006.The adjusted OR of having been vaccinated in 2010 with respect to 2003 was not significant 1.18 (95% CI: 0.97-1.44). We conclude that the levels of influenza vaccination coverage are below desirable levels among adults with diabetes. Furthermore, trend analysis in influenza vaccination coverage indicates that influenza vaccination rates in adults with diabetes have not improved in recent years. Urgent strategies for increasing vaccination coverage among diabetes sufferers are necessary especially for those aged 50-59, women, those without chronic conditions and those who are not frequent users of health care services.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23403458</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Human vaccines & immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain.</ArticleTitle><Pagination><MedlinePgn>1326-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4161/hv.23926</ELocationID><Abstract><AbstractText>A descriptive cross-sectional study was conducted for adults (aged ≥ 50 y) with diabetes. Data was obtained from the 2009 European Health Interview Survey for Spain and the 2003 and 2006 Spanish National Health Surveys. To assess influenza vaccination status, we considered the response (yes or no) to the question "Have you received the influenza vaccine in the previous season?" Both dependent and independent variables were based on the survey questionnaires. The independent variables analyzed included socio-demographic characteristics, health-related variables and use of health care services. The coverage among adults with diabetes in 2010 was 65.0% (95% CI: 62.1-67.7) compared with 41.2% (95% CI 40.0-42.4) for those without diabetes (p<0.01) adjusted OR 1.67 (95% CI: 1.40-1.99). The positive predictors of vaccine uptake among diabetic adults were: higher age, being male, the presence of associated chronic conditions and physician visits in the last 2 wk. The vaccine uptake among adults with diabetes was 61.4% (95% CI: 57.9-64.8) in 2003 and 63.8% (95% CI: 60.7-66.8) in 2006.The adjusted OR of having been vaccinated in 2010 with respect to 2003 was not significant 1.18 (95% CI: 0.97-1.44). We conclude that the levels of influenza vaccination coverage are below desirable levels among adults with diabetes. Furthermore, trend analysis in influenza vaccination coverage indicates that influenza vaccination rates in adults with diabetes have not improved in recent years. Urgent strategies for increasing vaccination coverage among diabetes sufferers are necessary especially for those aged 50-59, women, those without chronic conditions and those who are not frequent users of health care services.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jimenez-Trujillo</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Preventive Medicine Unit; Rey Juan Carlos University; Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>López-de Andrés</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hernández-Barrera</LastName><ForeName>Valentín</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Carrasco-Garrido</LastName><ForeName>Pilar</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Santos-Sancho</LastName><ForeName>Juana María</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Jiménez-García</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048909" MajorTopicYN="N">Diabetes Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055118" MajorTopicYN="Y">Medication Adherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coverage</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">trends</Keyword><Keyword MajorTopicYN="N">uptake</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23403458</ArticleId><ArticleId IdType="pii">23926</ArticleId><ArticleId IdType="doi">10.4161/hv.23926</ArticleId><ArticleId IdType="pmc">PMC3901826</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vaccine. 2003 Mar 28;21(13-14):1486-91</Citation><ArticleIdList><ArticleId IdType="pubmed">12615445</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2012 Jan;35 Suppl 1:S11-63</Citation><ArticleIdList><ArticleId IdType="pubmed">22187469</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2004 Dec 8;292(22):2715-2716</Citation><ArticleIdList><ArticleId IdType="pubmed">15585722</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2011;11:799</Citation><ArticleIdList><ArticleId IdType="pubmed">21995560</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Prev Med. 1999 Apr;16(3):173-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10198654</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2006 Aug;29(8):1771-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16873778</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Res Clin Pract. 2008 Mar;79(3):510-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18035444</ArticleId></ArticleIdList></Reference><Reference><Citation>Commun Dis Public Health. 2002 Jun;5(2):119-26</Citation><ArticleIdList><ArticleId IdType="pubmed">12166297</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Prev Med. 2000 Apr;18(3):215-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10722987</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2005 Aug;28(8):2031-3</Citation><ArticleIdList><ArticleId IdType="pubmed">16043751</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2005 Apr 1;54(RR-5):1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">15800472</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care. 2003 Sep;26(9):2562-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12941719</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Feb 1;29(6):1332-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21182996</ArticleId></ArticleIdList></Reference><Reference><Citation>J Prev Med Public Health. 2011 Jul;44(4):141-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21894062</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2012 Mar;8(3):363-70</Citation><ArticleIdList><ArticleId IdType="pubmed">22327503</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2012 Feb;8(2):228-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22426373</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Rep. 2007 Nov;18(4):9-19</Citation><ArticleIdList><ArticleId IdType="pubmed">18074993</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Psychogeriatr. 2013 Feb;25(2):328-38</Citation><ArticleIdList><ArticleId IdType="pubmed">23069128</ArticleId></ArticleIdList></Reference><Reference><Citation>Gac Sanit. 2006 Mar;20 Suppl 1:15-24</Citation><ArticleIdList><ArticleId IdType="pubmed">16539961</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Health Econ. 2013 Apr;14(2):211-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22072321</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Clin (Barc). 2012 Sep 22;139(7):284-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22015007</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Aug 31;28(38):6169-75</Citation><ArticleIdList><ArticleId IdType="pubmed">20659518</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2004 Nov 3;292(17):2089-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15523069</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 1999 Oct 29;48(42):961-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10553810</ArticleId></ArticleIdList></Reference><Reference><Citation>Wien Med Wochenschr. 2011 Mar;161(5-6):136-42</Citation><ArticleIdList><ArticleId IdType="pubmed">21253812</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Apr 5;29(16):2840-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21334388</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabet Med. 2001 Jul;18(7):599-603</Citation><ArticleIdList><ArticleId IdType="pubmed">11553193</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2009 Apr;8(4):425-33</Citation><ArticleIdList><ArticleId IdType="pubmed">19348558</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2006 Apr 4;144(7):465-74</Citation><ArticleIdList><ArticleId IdType="pubmed">16585660</ArticleId></ArticleIdList></Reference><Reference><Citation>Infection. 2009 Oct;37(5):390-400</Citation><ArticleIdList><ArticleId IdType="pubmed">19768382</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2006 Jan 30;24(5):622-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16169638</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 2003 Dec;93(12):2074-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14652337</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Jan 11;31(4):718-24</Citation><ArticleIdList><ArticleId IdType="pubmed">23153445</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country></list><tree><noCountry><name sortKey="Carrasco Garrido, Pilar" sort="Carrasco Garrido, Pilar" uniqKey="Carrasco Garrido P" first="Pilar" last="Carrasco-Garrido">Pilar Carrasco-Garrido</name><name sortKey="Hernandez Barrera, Valentin" sort="Hernandez Barrera, Valentin" uniqKey="Hernandez Barrera V" first="Valentín" last="Hernández-Barrera">Valentín Hernández-Barrera</name><name sortKey="Jimenez Garcia, Rodrigo" sort="Jimenez Garcia, Rodrigo" uniqKey="Jimenez Garcia R" first="Rodrigo" last="Jiménez-García">Rodrigo Jiménez-García</name><name sortKey="L Pez De Andres, Ana" sort="L Pez De Andres, Ana" uniqKey="L Pez De Andres A" first="Ana" last="L Pez-De Andrés">Ana L Pez-De Andrés</name><name sortKey="Santos Sancho, Juana Maria" sort="Santos Sancho, Juana Maria" uniqKey="Santos Sancho J" first="Juana María" last="Santos-Sancho">Juana María Santos-Sancho</name></noCountry><country name="Espagne"><noRegion><name sortKey="Jimenez Trujillo, Isabel" sort="Jimenez Trujillo, Isabel" uniqKey="Jimenez Trujillo I" first="Isabel" last="Jimenez-Trujillo">Isabel Jimenez-Trujillo</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000255 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000255 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23403458
|texte= Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23403458" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |